US Health and Human Services' Thompson set for talks with AdvaMed:
This article was originally published in Clinica
US Health and Human Services Secretary Tommy Thompson will demonstrate his continued interest in the medical device industry this week when he meets with AdvaMed's board of directors on June 20. Mr Thompson has been an outspoken advocate for medical device user fees and his drive to unite his sprawling sinecure into one department is already fostering greater co-operation within its various powerhouse health agencies. At AdvaMed's recent Device Submission Workshop, there was repeated talk about the US FDA collaborating with the National Institutes of Health, with Medicare administrators and with the Centers for Disease Control and Prevention.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.